BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 504706)

  • 21. [Long-term responders of non-Hodgkin's lymphoma: patients treated with combination chemotherapy].
    Nishihara R; Ohnoshi T; Oka A; Hayashi K; Sato M; Ueoka H; Yasuoka M; Sando Y; Kimura I
    Rinsho Ketsueki; 1982 Aug; 23(8):1192-7. PubMed ID: 6183469
    [No Abstract]   [Full Text] [Related]  

  • 22. Rituximab plus short-duration chemotherapy as first-line treatment for follicular non-Hodgkin's lymphoma: a phase II trial of the minnie pearl cancer research network.
    Hainsworth JD; Litchy S; Morrissey LH; Andrews MB; Grimaldi M; McCarty M; Greco FA
    J Clin Oncol; 2005 Mar; 23(7):1500-6. PubMed ID: 15632411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chemotherapy of MOPP and C-MOPP resistant cases of malignant lymphoma. (A preliminary report) (author's transl)].
    Kolarić K; Tomek R; Roth A
    Lijec Vjesn; 1980 Jun; 102(6):306-9. PubMed ID: 7453477
    [No Abstract]   [Full Text] [Related]  

  • 24. Liposome-encapsulated doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab in patients with lymphoma and concurrent cardiac diseases or pre-treated with anthracyclines.
    Rigacci L; Mappa S; Nassi L; Alterini R; Carrai V; Bernardi F; Bosi A
    Hematol Oncol; 2007 Dec; 25(4):198-203. PubMed ID: 17654614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Remission maintenance therapy of non-Hodgkin's lymphoma with CHOP protocol].
    Toki H; Okabe K; Ishikawa M; Fujii M; Kimura Y
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):260-4. PubMed ID: 6546489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Adriamycin-based combination chemotherapy in the treatment of advanced malignant lymphoma. A progress report].
    Sampi K; Honda T; Hattori M
    Gan To Kagaku Ryoho; 1984 May; 11(5):1012-7. PubMed ID: 6202245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
    Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.
    Engert A; Diehl V; Franklin J; Lohri A; Dörken B; Ludwig WD; Koch P; Hänel M; Pfreundschuh M; Wilhelm M; Trümper L; Aulitzky WE; Bentz M; Rummel M; Sezer O; Müller-Hermelink HK; Hasenclever D; Löffler M
    J Clin Oncol; 2009 Sep; 27(27):4548-54. PubMed ID: 19704068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
    Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B;
    Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [ Long-term evaluation of the effect of a chemotherapy protocol using vincristine, adriamycin, procarbazine and prednisone (VAPP) on advanced Hodgkin's disease].
    Marinone G; Colle R; Mombelloni P
    Minerva Med; 1978 Apr; 69(18):1255-61. PubMed ID: 662153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biweekly CHOP-E chemotherapy for aggressive non-Hodgkin's lymphoma].
    Hayashi T; Takahashi T; Mihara M; Shimizu H; Tsukuda H; Kobayashi T; Adachi M; Hinoda Y; Aoki S; Mori M; Tsujisaki M; Imai K
    Gan To Kagaku Ryoho; 1997 May; 24(7):889-91. PubMed ID: 9170532
    [No Abstract]   [Full Text] [Related]  

  • 32. [A comparative study of mitoxantrone and adriamycin in patients with non-Hodgkin's lymphoma: a preliminary result].
    Kimura I; Ohnoshi T; Masaoka T; Sampi K; Namba K
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2813-9. PubMed ID: 3530138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
    Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W
    J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combinations of methotrexate (COP or CHOP) in the treatment of previously untreated and treated lymphomas.
    Gomez GA; Stutzman L; Moayeri H; Shimaoka K; Plager J; Han T; Naeher C; Henderson E
    Cancer Treat Rep; 1982 Jan; 66(1):43-7. PubMed ID: 6975659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major prognostic factors of adult patients with advanced B-cell lymphoma treated with vincristine, cyclophosphamide, prednisone and doxorubicin (VEPA) or VEPA plus methotrexate (VEPA-M).
    Shimoyama M; Ota K; Kikuchi M; Yunoki K; Konda S; Takatsuki K; Ogawa M; Tominaga S; Tsugane S; Minato K
    Jpn J Clin Oncol; 1988 Jun; 18(2):113-24. PubMed ID: 3379782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of leukemic non-Hodgkin lymphoma with DIC, which was induced into complete remission by DCOP-therapy (author's transl)].
    Nakanishi S; Yamazaki H; Kono Y; Nakata T; Nishio A; Haruyama H; Katsuki A; Nakagawa M; Sugishima K; Ijichi H; Isemura T
    Rinsho Ketsueki; 1981 Jun; 22(6):896-902. PubMed ID: 7334616
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of malignant lymphoma: 12 years' experience with 109 patients. 2). Treatment of non-Hodgkin's lymphoma].
    Furukawa Y; Takagi S; Tsuboyama A; Tsunoda S; Akashi M; Komatsu N; Takeda K; Muroi K; Akutsu M; Ohsaka A
    Rinsho Ketsueki; 1987 Sep; 28(9):1544-52. PubMed ID: 3437516
    [No Abstract]   [Full Text] [Related]  

  • 38. Hematologic malignancies: non-Hodgkin's lymphomas.
    DeVita VT
    Hosp Pract (Off Ed); 1986 Sep; 21(9):103-18. PubMed ID: 2427535
    [No Abstract]   [Full Text] [Related]  

  • 39. [Palliative chemotherapy of adult soft tissue sarcomas with an association of cyclophosphamide-vincristine-adriamycine-dacarbazine (CYVADIC) (author's transl)].
    Bui B; Chauvergne J; Durand M; Brunet R
    Bull Cancer; 1981; 68(1):1-5. PubMed ID: 7225604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combination chemotherapy of primary gastric lymphoma with vincristine, endoxan (cyclophosphamide), prednisolone and adriamycine (VEPA)].
    Takenaka T; Konda C; Sakano T; Shimoyama M; Kitahara T; Minato K; Kitaoka H
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):323-9. PubMed ID: 6897859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.